- Home
- ANIP vs COMM Comparison
ANIP vs COMM Comparison
Compare ANIP & COMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- COMM
- Stock Information
- Founded
- ANIP 2001
- COMM 1976
- Country
- ANIP United States
- COMM United States
- Employees
- ANIP N/A
- COMM N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- COMM Radio And Television Broadcasting And Communications Equipment
- Sector
- ANIP Health Care
- COMM Technology
- Exchange
- ANIP Nasdaq
- COMM Nasdaq
- Market Cap
- ANIP 1.2B
- COMM 1.1B
- IPO Year
- ANIP N/A
- COMM 2013
- Fundamental
- Price
- ANIP $61.52
- COMM $4.76
- Analyst Decision
- ANIP Buy
- COMM Hold
- Analyst Count
- ANIP 8
- COMM 5
- Target Price
- ANIP $79.71
- COMM $3.00
- AVG Volume (30 Days)
- ANIP 275.5K
- COMM 5.9M
- Earning Date
- ANIP 05-09-2025
- COMM 05-08-2025
- Dividend Yield
- ANIP N/A
- COMM N/A
- EPS Growth
- ANIP N/A
- COMM N/A
- EPS
- ANIP N/A
- COMM N/A
- Revenue
- ANIP $614,376,000.00
- COMM $4,205,800,000.00
- Revenue This Year
- ANIP $26.80
- COMM $21.62
- Revenue Next Year
- ANIP $6.89
- COMM $8.76
- P/E Ratio
- ANIP N/A
- COMM N/A
- Revenue Growth
- ANIP 26.20
- COMM N/A
- 52 Week Low
- ANIP $52.50
- COMM $0.86
- 52 Week High
- ANIP $70.81
- COMM $7.19
- Technical
- Relative Strength Index (RSI)
- ANIP 60.64
- COMM 42.79
- Support Level
- ANIP $57.72
- COMM $4.48
- Resistance Level
- ANIP $64.43
- COMM $5.01
- Average True Range (ATR)
- ANIP 2.77
- COMM 0.43
- MACD
- ANIP 0.50
- COMM -0.12
- Stochastic Oscillator
- ANIP 86.50
- COMM 20.19
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).